Mechanism of AIMP2-DX2 interaction with KRAS and screening of DX2 inhibitors revealed potential for DX2-targeted therapeutics to control KRAS-driven cancers

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.